Department of Social Pharmacy, School of Pharmacy, University of Oslo, Blindern, Oslo, Norway.
Adv Ther. 2010 Feb;27(2):118-26. doi: 10.1007/s12325-010-0007-8. Epub 2010 Mar 16.
Efforts to restrain pharmaceutical costs in the Norwegian hospital sector have focused on putting pharmaceuticals out to tender with resultant frequent changes in medicine inventories. Due to the extent of physicians failing to prescribe from the hospital drug list, the nurses have to perform generic substitution on the wards. The objective of the present study is to investigate the hospital nurses' experiences with generic substitution and to explore their views on this strategy as a risk factor for medication errors.
Personal interviews with 100 nurses who were employed in a large Norwegian hospital were conducted using a semistructured questionnaire.
In all, 75% of nurses thought it was problematic that the hospital's drug inventory was subject to frequent changes, and 91% believed that the high number of generic products may contribute to erroneous dispensing. Nevertheless, three out of four admitted that they seldom or never verified the feasibility of the substitution with the physician, and that it was seldom documented in the medical charts. In total, 42% of the nurses had experienced mistakes that occurred as a result of substitution. They claimed that the medication errors relating to generic substitution derived from difficult drug names, frequent changes in the drug inventory, and the increasing number of generic drugs, as well as from heavy workload and insufficient training.
The present study shows that generic substitution is often carried out by nurses on the wards. The nurses feel insecure about the situation and report that they do not have the necessary training for the task. They clearly believe that a high number of generic drugs and frequent generic substitutions are risk factors for medication errors. Hence, hospital managers should be aware that such strategies to reduce costs may interfere with patient safety.
挪威医院部门为控制药品成本所做的努力集中在对药品进行招标,这导致药品清单经常发生变化。由于医生未能从医院药品清单中开出处方的情况很普遍,护士不得不在病房进行仿制药替代。本研究的目的是调查医院护士对仿制药替代的经验,并探讨他们对这种策略作为药物错误风险因素的看法。
采用半结构式问卷,对在一家大型挪威医院工作的 100 名护士进行个人访谈。
共有 75%的护士认为医院药品清单经常变化的问题很严重,91%的护士认为大量的仿制药可能会导致错误配药。然而,四分之三的护士承认他们很少或从未与医生核实替代的可行性,而且很少在病历中记录。总的来说,42%的护士经历过因替代而导致的错误。他们声称,与仿制药替代相关的药物错误源于药品名称难记、药品清单频繁变化、仿制药数量不断增加,以及工作量大且培训不足。
本研究表明,仿制药替代通常由病房护士进行。护士对这种情况感到没有安全感,并报告说他们没有完成这项任务所需的培训。他们清楚地认为,大量的仿制药和频繁的仿制药替代是药物错误的风险因素。因此,医院管理人员应该意识到,这种降低成本的策略可能会干扰患者安全。